Accesso libero

Array-comparative genomic hybridization results in clinically affected cases with apparently balanced chromosomal rearrangements

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Comparison with the previous reports for postnatal de novo patients.

StudyArray PlatformTranslocationInversionCCRsTotalImbalances at the BreakpointImbalances at Different Breakpoint Regions
[13]1 Mb BAC5/8 (62.5)0/2 (0.0)5/10 (50.0)2/10 (20.0)3/10 (30.0)
[11]Agilent 44K or 244k11/27 (40.0)12/13 (92.3)23/40 (57.5)16/40 (40.0)7/40 (17.5)
[37]Agilent Genomics 244k/2600, BAC, Spectral4/9 (44.4)4/9 (44.4)1/9 (11.1)3/9 (33.3)
[34]aWhole Genome Tilepath 30k4/11 (36.3)1/2 (50.0)5/13 (38.4)4/13 (30.7)1/13 (7.7)
[5]Cytochip Bluegnome 1 Mb2/6 (33.2)2/6 (33.2)1/6 (16.6)1/6 (16.6)
[14]Agilent 44K or 244k8/21 (38.1)4/7 (57.1)4/5 (80.0)16/33 (48.5)9/33 (27.3)7/33 (21.2)
[16]aAffymetrix GeneChip 250k3/3 (100.0)2/2 (100.0)5/5 (100.0)2/5 (40.0)3/5 (60.0)
[12]a32250k k BAC, Affymetrix 105k/244k Agilent,11/40 (27.5)0/6 (0.0)7/8 (87.5)18/54 (33.3)11/54 (20.3)7/54 (13.0)
[15]a370k, 370-Duo Illumina2/5 (40.0)2/4 (50.0)4/9 (44.4)2/9 (22.2)2/9 (22.2)
[17]135k NimbleGen CGX-33/7 (43.0)1/4 (25.0)4/11 (36.4)3/11 (27.3)1/11 (9.1)
[38]SNP 6.0/750k Affymetrix1/11 (9.0)0/3 (0.0)1/1 (100.0)3/15 (20.0)1/15 (6.7)2/15 (13.3)
This study1.4M NimbleGen CGX-3/ 180k Agilent1/5 (20.0)1/1 (100.0)5/8 (62.5)7/14 (50.0)2/14 (14.3)5/14 (35.7)
Total55/153 (35.9)10/27 (37.0)29/39 (74.4)96/219 (43.8)54/219 (24.6)42/219 (19.2)

Clinical findings, karyotype and chromosomal microarray results for the postnatal patients.

#Sex- AgeClinical DetailsInitial KaryotypeCMA Result (GRCh37/hg19]SizeType of Anomaly (gain/loss)Parental Origin of Imbalance
Translocations
1aM-4consanguineous marriage; stereotypic hand movements, PSMR; short eye contact duration; pathology in brain MRI; ASD46,XY,t(4;10)(q34.2;q26.2)10q26.3 (130669231-135534747)x34.8 Mbgainde novo
2aM-13minimal nonspecific ID; hypo-glycemia; cryptorchidism; facial dysmorphism; short neck; hypo-myelinization and subarachnoid enlargement in cranial CT46,XY,t(4;10)(q25;q22.1)normal
3aM-6PSMR; anal stenosis; bilateral inguinal hernia; facial dysmorphism; macrocephaly; short fingers and clinodactyly on the fifth finger46,XY,t(5;17)(q12.2;q21.33)normal
4aM-4PSMR; drug therapy due to convulsion; facial dysmorphism; pes planus46,XY,t(2;10)(q33.2;p12.32)normal
5aF-7PSMR; hypotonia; central obesity; childhood polyphagia46,XX,t(6;9)(q25.1;q32)normal
6bM-11consanguineous marriage; ID; hyperactivity; poor eye contact, repetitive speech; family history of MR (paternal side); fragile X test normal46,XY,t(9;10)(p22;q24)patnormal
7bM-13consanguineous marriage; mild ID; brother and maternal aunt’s daughter affected; microphthalmia; severe PSMR; muscle atrophy; microcephaly; bilateral hydronephrosis; facial dysmorphism46,XY,t(6;19)(p11;p13.2)matnormal
8bF-9consanguineous marriage; microcephaly; facial dysmorphism; clinodactyly; cranial CT consistent with Lissencephaly type 146,XX,t(3;4)(p22;q26)mat (negative FISH result for Smith- Magenis-Dieker Probe)normal
9bM-1consanguineous marriage; facial dysmorphism; CHD; right kidney agenesis, left kidney size increase; undescended testicle; anal atresia46,XY,t(8;22)(p11.2;q22)matnormal
Inversions
10aF-7neuromotor retardation; seizures; growth retardation; microcephaly; facial dysmorphism; clinodactyly; pathology in brain MRI46,XX,inv(1)(q25.1q32.2)1q23.3q24.2(161969134-169579696)x17.6 Mblossde novo
11bM-13ID; undescended testicle; advanced bone age; obesity; agitation; fragile X test normal46,XY,parinv(12)(p13.3q13.1)patnormal
12bM-3consanguineous marriage; PSMR; growth retardation; microcephaly; facial dysmorphism; clinodactyly; joint hypermobility46,XY,inv(12)(p11q14)matnormal
13bM-5consanguineous marriage; pectus excavates; pulmonary stenosis; cryptorchidism, micropenis; lytic bone lesions; mutation negative in RAF1, KRAS, SHOC2 genes46,XY,parinv(12)(q21.2q24.1)matnormal
Complex Chromosome Rearrangements
14aM-4PSMR; hypotonia; microcephaly; syndactyly; lack of eye contact46,XY,t(8;13)(q24.13;q21.2), ins(2)(p16.2q33.2q22.2)2q36.1q36.3(225194399-228263782)x13.0 Mblossde novo
15aM-9PSMR; alopecia; hyperpigmentation; facial dysmorphism; bilateral cubitus valgus; accessory nipple on bilateral nipple line; tracheostomy46,XY,inv(3)(p13p25)t(11;18) (p13.5;q12.2)4q13.3(71013108-72174576)x1 4q13.3q21.2(73373677-76306815)x11.1 Mb 2.9 Mbloss lossde novo
16aM-1bilateral aniridia; cryptorchidism; micropenis; heart murmur; hypertonia of the lower extremities46,XY,t(3;15;21)(p13;q21.1; q22.3),t(4;16)(q31;p31.1)11p14.13(30031595-33045209)x12.5 Mblossde novo
17aF-3PSMR; microcephaly; dystrophinopathy; myogenic EMG findings; walking difficulties46,X,t(X;13;17)(p21;q13;q22)normal
18M-3CHD; negative FISH result for DiGeorge syndrome46,XY,der(3)(15qter→15q22.3: :3p11.2→3qter)der(15)(15pter→ 15q22.3::3p26→3p11.2: :3p26→3pter)normal
19aF-13mild ID; dystrophinopathy; Gowers’ sign; pektus ekskavatum; minimal facial dysmorphism; normal MLPA result46,X,t(X;8;14)(8qter→8q11: :Xp21→Xqter)(Xpter→Xp21: :8p21.1→8q11::14q13)normal
20aM-4consanguineous marriage; neuromotor retardation; mild ID; facial dysmorphism; brachycephaly; hypoplastic scrotum46,XY,t(1;18)(q32.1;q23),t(5;12) (p14.2;q21.2)5q13.3-q14.1(74571645-77654540)x1 5q14.3(90604937-92259476)x1 5q15(93668778-95921236)x1 9p23p22.3(14030668-16317401)x12.4 Mb 1.6 Mb 1.9 Mb 2.3 Mbloss loss loss lossde novo
21aF-2facial dysmorphism; short neck; soft, dry skin; clinodactyly; bilateral clubfoot, talipes echi- novarus; hypoplastic clitoris; tooth grinding; multiple renal stones; partial ACC; normal MLPA result46,XX,t(11;13;18)(13pter→ 13q22::11p13→11pter; 13qter→13q22::11p13→11q24: :18q21→18qter;18pter→18q21: :11q24→11qter)11p14.3(22454510-246887178)x1 18q21.2q21.32(48286848-58934492)x1 21q11.2q21.1(15598880-18332856)x12.2 Mb 10.6 Mb 2.7 Mbloss loss lossde novo

Ultrasonography findings, karyotype and chromosomal microarray results for the prenatal patients.

#Weeks’ Gestation/ Invasive ProcedureUSG FindingsInitial KaryotypeCMA Result (GRCh37/hg19]SizeType of Anomaly (gain/loss)Parental Origin of Imbalance
Translocations
22a24/CVSNT (5 mm)46,XX,t(2;4)(p23;q31.1)normal
23a21/ACabdominal cysts; polyhydramnios46,XY,t(10;16)(q23.2;q13)10q23.1(86441275-87680071)x11.2 Mblossde novo
24a24/ACdilated intestine; EIF46,XX,t(7;12)(q36;q15)normal
25a17/ACCPCs; fetal intracranial cysts46,XY,t(2;3)(q31.2;q27.32)normal
26a19/ACCPCs46,XX,t(3;16)(p21.3q11)16p11.2(28220816-33816801)x35.5 Mbgainmaternal
27a23/ACSUA; HEB; increased cardiothoracic ration46,XY,t(5;13)(q15;q22)normal
28a20/ACbilateral ventriculomegaly; hydrochephalus46,XX,t(8;16)(q24.1;q12.1)normal
29b24/ACasymmetric ventriculomegaly46,XY,t(15;17)(q24.1;q21.3)patnormal
30b22/FBSbilateral pes equinovarus; amniotic band sequence46,XY,t(11;15)(q13.3;q25)patnormal
Inversions
31b23/FBSsitus inversus totalis, CHD46,XY,inv(12)(p11.23q15)matnormal
32b22/ACanhydramnios; laryngeal atresia; bilateral renal agenesis; SUA; absence/hypoplasia of lower extremities; ambiguous genitalia46,XX,inv(7)(q11.2q32)matnormal
33b24/FBSascites; polyhydramnios; IUMF; increased cardiothoracic ratio; thick placenta46,XX,inv(6)(q21.2q26)patnormal
Complex Chromosome Rearrangements
34a23/FBSIUGR; ambiguous genitalia; micropenis; hand and foot deformities; ASD46,XY,t(1;9;11)(1pter→1q43: :9p22.2→9pter;11pter→ 11p11.22::9p21→9qter)normal
eISSN:
1311-0160
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicine, Basic Medical Science, other